Home

бял дроб наклонен прогрес iga kappa t 4 14 белезници съгласна Станете наясно

Multiple myeloma - The Lancet
Multiple myeloma - The Lancet

PDF) Oncology and Radiotherapy © Outcome of stage III-B IgA-Kappa FLC MM  with t(4:14) karyotype: A Nigerian jehovah witness nine-year experience
PDF) Oncology and Radiotherapy © Outcome of stage III-B IgA-Kappa FLC MM with t(4:14) karyotype: A Nigerian jehovah witness nine-year experience

Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in  patients with relapsed/refractory multiple myeloma: A single center  analysis. - Abstract - Europe PMC
Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis. - Abstract - Europe PMC

The t(4;14) is associated with poor prognosis in myeloma patients  undergoing autologous stem cell transplant - Chang - 2004 - British Journal  of Haematology - Wiley Online Library
The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant - Chang - 2004 - British Journal of Haematology - Wiley Online Library

Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA  responses | Mucosal Immunology
Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA responses | Mucosal Immunology

Frontiers | Assessment of Molecular Residual Disease Using Circulating  Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse
Frontiers | Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse

Precision Medicine for Relapsed Multiple Myeloma on the Basis of an  Integrative Multiomics Approach | JCO Precision Oncology
Precision Medicine for Relapsed Multiple Myeloma on the Basis of an Integrative Multiomics Approach | JCO Precision Oncology

Cancers | Free Full-Text | Genome Instability in Multiple Myeloma: Facts  and Factors | HTML
Cancers | Free Full-Text | Genome Instability in Multiple Myeloma: Facts and Factors | HTML

Cureus | Factors Explaining the Coincidence of Smoldering Multiple Myeloma  and Primary Biliary Cholangitis: A Case Report
Cureus | Factors Explaining the Coincidence of Smoldering Multiple Myeloma and Primary Biliary Cholangitis: A Case Report

Disease monitoring with quantitative serum IgA levels provides a more  reliable response assessment in multiple myeloma patients | Leukemia
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia

Characterisation of immunoparesis in newly diagnosed myeloma and its impact  on progression-free and overall survival in both old and recent myeloma  trials | Leukemia
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia

t(11;14) and t(4;14) translocations correlated with mature  lymphoplasmacytoid and immature morphology, respectively, in multiple  myeloma | Leukemia
t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma | Leukemia

Single-center Experience in Treating Patients With t(4;14) Multiple Myeloma  With and Without Planned Frontline Autologous Stem Cell Transplantation -  ScienceDirect
Single-center Experience in Treating Patients With t(4;14) Multiple Myeloma With and Without Planned Frontline Autologous Stem Cell Transplantation - ScienceDirect

Multiple Myeloma and the 4;14 Translocation - HealthTree for Myeloma
Multiple Myeloma and the 4;14 Translocation - HealthTree for Myeloma

Frontiers | Case Report: ITP Treatment After CAR-T Cell Therapy in Patients  With Multiple Myeloma
Frontiers | Case Report: ITP Treatment After CAR-T Cell Therapy in Patients With Multiple Myeloma

IJMS | Free Full-Text | Next-Generation Biomarkers in Multiple Myeloma:  Understanding the Molecular Basis for Potential Use in Diagnosis and  Prognosis | HTML
IJMS | Free Full-Text | Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis | HTML

IgA-producing lymphoplasmacytic lymphoma carrying the chromosomal  abnormality t(8;14)
IgA-producing lymphoplasmacytic lymphoma carrying the chromosomal abnormality t(8;14)

Light chain myeloma: A brief report from India Singh N, Agrawal N, Sekhri  R, Mehta A, Kumar D, Vishwakarma G, Ahmed R, Bhurani D - Indian J Pathol  Microbiol
Light chain myeloma: A brief report from India Singh N, Agrawal N, Sekhri R, Mehta A, Kumar D, Vishwakarma G, Ahmed R, Bhurani D - Indian J Pathol Microbiol

The t(4;14) translocation and IgH-MMSET hybrid RT-PCR assays. (A)... |  Download Scientific Diagram
The t(4;14) translocation and IgH-MMSET hybrid RT-PCR assays. (A)... | Download Scientific Diagram

Multiple myeloma - Wikipedia
Multiple myeloma - Wikipedia

Co-evolution of tumor and immune cells during progression of multiple  myeloma | Nature Communications
Co-evolution of tumor and immune cells during progression of multiple myeloma | Nature Communications

Interphase FISH analysis for detection of t(11;14)(q13; 32). Red... |  Download Scientific Diagram
Interphase FISH analysis for detection of t(11;14)(q13; 32). Red... | Download Scientific Diagram

Gut-educated IgA plasma cells defend the meningeal venous sinuses | Nature
Gut-educated IgA plasma cells defend the meningeal venous sinuses | Nature

Sergio Giralt defends the PRO position To Maintain or Not to Maintain The  Answer is Yes And Lenalidomide is the Right Choice. - ppt download
Sergio Giralt defends the PRO position To Maintain or Not to Maintain The Answer is Yes And Lenalidomide is the Right Choice. - ppt download

Myeloma kidney: the importance of assessing the response by monitoring free  light chains in serum | Nefrología
Myeloma kidney: the importance of assessing the response by monitoring free light chains in serum | Nefrología

Biomedicines | Free Full-Text | The Cytogenetic Profile of Primary and  Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic  Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with  Differential Circulating Clonal Plasma
Biomedicines | Free Full-Text | The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma